Difloxacin hydrochloride

CAS No. 91296-86-5

Difloxacin hydrochloride( Difloxacin HCl )

Catalog No. M21203 CAS No. 91296-86-5

Difloxacin hydrochloride is a fluoroquinolone antibiotic is a broad-spectrum antibacterial drug.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 32 In Stock
200MG Get Quote In Stock
500MG 77 In Stock
1G 111 In Stock

Biological Information

  • Product Name
    Difloxacin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Difloxacin hydrochloride is a fluoroquinolone antibiotic is a broad-spectrum antibacterial drug.
  • Description
    Difloxacin hydrochloride is a fluoroquinolone antibiotic is a broad-spectrum antibacterial drug.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Difloxacin HCl
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    91296-86-5
  • Formula Weight
    435.8
  • Molecular Formula
    C21H20ClF2N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:5 mg/mL (11.47 mM; ultrasonic and warming and heat to 60°C)
  • SMILES
    CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Abo El-Ela F I Radi A M El-Banna H A et al. Pharmacokinetics of difloxacin in healthy and\r?E. coli\r -infected broiler chickens[J]. British Poultry Science 2014 55(6):830-836.
molnova catalog
related products
  • Carvacrol methyl eth...

    Carvacrol methyl ether is derived from plant volatile oil and exhibits antibacterial activity.

  • Antimicrobial Compou...

    Antimicrobial Compound 1 is an alkyl pyridinium compound with Tail 12C, Head 4-carboxyl. Antimicrobial Compound 1 exhibits antimicrobial activities against B. subtilis and E. coli.

  • PBP 10

    Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.